CLL is characterized by a dynamic imbalance between the proliferation and apoptosis of neoplastic B-lymphocytes co-expressing CD5 and CD19 antigens [19], [20], [21]. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.